10-K: HealthEquity Reports Strong Growth in Accounts, Assets, and Profit

Sentiment:

Annual Report


HealthEquity, Inc. announced robust financial results for the fiscal year ended January 31, 2026, driven by significant increases in HSA assets and net income, alongside strategic technology investments and operational efficiencies.

Capital raiseMaintains a shelf registration statement on Form S-3, allowing for future offerings of securities for general corporate purposes, including working capital, capital expenditures, debt repayment, and acquisitions.May conduct concurrent or other financings at any time.While existing cash, cash equivalents, and the Revolving Credit Facility are expected to be sufficient for the next 12 months, additional financing may be required if these sources are insufficient for future business activities and requirements.
Better than expectedNet income increased by 123% year-over-year to $215.2 million.Adjusted EBITDA increased by 20% year-over-year to $566.0 million.Total revenue increased by 9% year-over-year to $1,313.4 million.Total HSA Assets grew by 14% to $36.5 billion and HSAs by 7% to 10.6 million.Custodial revenue increased by 17%, driven by higher yields and increased Enhanced Rates offering adoption.Service costs decreased by 7% due to operational efficiencies and reduced fraud impact.

Summary

  • Administered 10.6 million Health Savings Accounts (HSAs) and 7.2 million complementary Consumer-Directed Benefits (CDBs) as of January 31, 2026, totaling 17.8 million Total Accounts.
  • HSA Assets reached $36.5 billion as of January 31, 2026, marking a 14% increase from the previous year.
  • Total revenue increased by 9% to $1,313.4 million for the fiscal year ended January 31, 2026.
  • Net income surged by 123% to $215.2 million for the fiscal year ended January 31, 2026.
  • Adjusted EBITDA increased by 20% to $566.0 million for the fiscal year ended January 31, 2026.
  • Maintained market leadership as the largest HSA provider by number of accounts and the second largest by HSA Assets as of June 2025.
  • Acquired the BenefitWallet HSA portfolio in fiscal 2025, adding approximately 616,000 HSAs and $2.7 billion of HSA Assets.
  • Investing in technology modernization, including AI tools, to enhance security, privacy, and platform infrastructure.
  • The 'One Big Beautiful Bill Act,' signed in July 2025, expanded HSA availability to individuals with Bronze and Catastrophic health plans and broadened HSA eligibility to include a wider range of healthcare services.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong report, highlighting significant financial growth, market leadership, and strategic investments in technology and acquisitions, despite some ongoing operational cost increases and legal challenges.

Positives

  • Total revenue increased 9% to $1,313.4 million for the fiscal year ended January 31, 2026.
  • Net income increased 123% to $215.2 million for the fiscal year ended January 31, 2026.
  • Adjusted EBITDA increased 20% to $566.0 million for the fiscal year ended January 31, 2026.
  • HSAs grew 7% to 10.6 million and Total HSA Assets grew 14% to $36.5 billion as of January 31, 2026.
  • HSA investments increased 26% to $18.5 billion as of January 31, 2026.
  • Custodial revenue increased 17% to $636.8 million, driven by a higher average annualized yield on HSA cash (3.53% in FY26 vs. 3.11% in FY25) and increased participation in the Enhanced Rates offering (58% of HSA cash in FY26 vs. 49% in FY25).
  • Service costs decreased 7% due to efficiencies from technology investments and a decrease in costs incurred to reimburse members impacted by outside fraud activity.
  • Interchange costs decreased 10% due to efficiencies resulting from the transition to a single card processor.
  • Successfully acquired the BenefitWallet HSA portfolio in fiscal 2025, adding 616,000 HSAs and $2.7 billion in HSA Assets.
  • The 'One Big Beautiful Bill Act' (July 2025) expanded HSA availability and eligibility, providing a legislative tailwind for growth.
  • Ongoing modernization of proprietary technology platforms, including increasing use of AI tools, to enhance security, privacy, and platform infrastructure.
  • Strong retention rates for HSA members due to inherent switching costs and integrated platform.
  • Management concluded that internal control over financial reporting was effective as of January 31, 2026.

Negatives

  • The increase in service revenue was partially offset by lower average service fees per account.
  • Sales and marketing expenses increased 5% primarily due to increases in advertising expenses.
  • Technology and development expenses increased 10% primarily due to increases in software costs and personnel-related expenses.
  • General and administrative expenses are expected to increase annually due to the normalization of stock-based compensation expense and additional demands on legal, compliance, and finance functions.
  • Experienced a significant increase in the volume and sophistication of outside fraudulent activity targeting member accounts in the fiscal year ended January 31, 2025, and the fiscal quarter ended April 30, 2025, resulting in significant losses and reputational damage.
  • Experienced a data privacy incident in 2024 where a business partner's user account containing personally identifiable information was breached, leading to consolidated putative class action lawsuits and regulatory inquiries.

Risks

  • Any diminution in, elimination of, or change in the availability of tax benefits for HSAs and other CDBs would materially adversely affect the business.
  • Failure to adequately place and safeguard HSA cash and Client-held funds, or the failure of any insurance company partners or Depository Partners, could materially and adversely affect the business.
  • A decline in interest rates would reduce income on HSA Assets and Client-held funds and the ability to attract HSA contributions.
  • A decline in the value of invested HSA Assets would adversely affect results of operations.
  • Inability to adapt to a rapidly evolving industry, characterized by rapid technological change, new product/service introductions, and evolving standards, could limit growth and adversely affect the business.
  • Any diminution in the use of HSAs or other CDBs (e.g., lack of consumer familiarity, employers reducing offerings, decreased adoption rates) would materially adversely affect the business.
  • The expanding use or anticipated use of AI technologies, including generative AI, by the company or third parties, may increase or create new operational and competitive risks, such as flaws in models, ethical considerations, potential intellectual property infringement, data exposure, and evolving regulations.
  • Inability to compete effectively against current and future competitors, including well-known retail investment companies (e.g., Fidelity Investments), healthcare service companies (e.g., UnitedHealth Group's Optum, Webster Bank), and Network Partners offering competitive services directly.
  • Developments in the rapidly changing healthcare industry, such including decreased spending, government regulation, consolidation, or 'Medicare for all' plans, could adversely affect the business.
  • If members do not continue to utilize payment cards, interchange revenue would be materially adversely affected.
  • Failure to operate the marketplace effectively, negative response from Network Partners, Clients, or members, or disruption of marketplace partners, products, or services could adversely affect the business.
  • Failure to maintain effective internal control over financial reporting could have a material adverse effect on reputation, results of operations, and financial condition.
  • Cyber attacks, including ransomware attacks, or other privacy or data security incidents could materially adversely impact the business, leading to regulatory scrutiny, legal claims, and reputational damage.
  • Fraudulent activity, whether involving member accounts or third-party service providers, has led, and could continue to lead, to financial and reputational damage.
  • Reliance on software licensed from third parties that may be difficult to replace or that could cause errors or failures of technology platforms.
  • Developing and implementing new and updated applications, features, and services for technology platforms may be more difficult, take longer, cost more, or not operate as expected.
  • Disruptions of service at facilities, servers, third-party data centers, or cloud service providers have interrupted and delayed customer access and will be harmful if repeated.
  • Technology platforms may link to or utilize open source software, and any failure to comply with the terms of one or more of these open source licenses could negatively affect the business.
  • The healthcare regulatory and political framework is uncertain and evolving, and further healthcare reform and other changes in government programs may have an adverse effect on the business.
  • Changes in applicable federal and state laws relating to HSAs and other CDBs could materially adversely affect the business.
  • Subject to privacy regulations (e.g., GLBA, HIPAA, state laws), and privacy breaches could result in substantial financial and reputational harm, including possible criminal and civil penalties.
  • Legislative, regulatory, and legal developments involving taxes could adversely affect results of operations and cash flows.
  • Regulatory changes and changes in the enforcement environment may have an adverse result on the business.
  • Changes in laws and regulations relating to interchange fees on payment card transactions could adversely affect revenue and results of operations.
  • Failure to comply with, or changes in, payment card industry, credit card association, or other network rules or standards could materially adversely affect the business.
  • Subject to complex regulation (e.g., IRS, HHS, DOL, ERISA, HIPAA, Advisers Act, state banking laws, AI regulation), and any compliance failures or regulatory action could adversely affect the business.
  • Inability to meet or exceed the net worth test required by the IRS could prevent maintaining non-bank custodian status.
  • Any failure to offer high-quality member, Client, and Network Partner support services could adversely affect relationships and operating results.
  • Reliance on management team and team members, and the business could be harmed if unable to retain qualified personnel.
  • Inability to maintain corporate culture as the company grows could lead to loss of innovation, teamwork, passion, and focus on execution.
  • If Network Partners choose to partner with other providers of, or otherwise reduce offering or cease to offer, products and services, the business could be materially and adversely affected.
  • A change in relationship with the bank identification number (BIN) sponsor, or the failure by the sponsor to comply with certain banking regulations, could materially and adversely affect the business.
  • Replacing third-party service providers would be difficult and disruptive to the business.
  • Acquisition and investment strategies may not be successful, and the company may not realize the synergies anticipated from acquisitions.
  • Failure to manage future growth effectively could have a material adverse effect on the business.
  • Inaccurate estimation of the impact on the business of developing, introducing, and updating new and existing products and services.
  • Need to record write-downs from future impairments of identified intangible assets and goodwill.
  • Substantial debt could limit the ability to fund operations, expose the company to interest rate volatility, limit the ability to raise additional capital, and have a material adverse effect on the ability to fulfill obligations.
  • Provisions in charter documents and under Delaware law could discourage a takeover that stockholders may consider favorable.
  • The exclusive forum provision in the amended and restated certificate of incorporation could limit stockholders' ability to obtain a favorable judicial forum for disputes.

Future Outlook

The Company expects service revenue, interchange revenue, and custodial revenue to continue to increase, driven by growth in Total Accounts, HSA investments, and higher average annualized yields on HSA cash as existing Depository Partner agreements are renewed. Service costs are projected to remain relatively steady due to operational efficiencies, while custodial and interchange costs are expected to increase with account growth. Sales and marketing, and technology and development expenses are anticipated to rise due to continued investment in brand awareness, engagement programs, and proprietary technology modernization, including AI. General and administrative expenses are also expected to increase annually. Amortization of acquired intangible assets is projected to decrease. The Company believes its current liquidity sources will be sufficient for the next 12 months, and tax payments for the upcoming fiscal year are expected to be significantly reduced due to recent legislative changes, though the overall tax expense and effective tax rate are not expected to materially change.

Management Comments

  • We are a leader and an innovator in providing technology-enabled services that empower consumers to make healthcare saving, spending, and investing decisions.
  • We believe the shift to greater consumer responsibility for healthcare costs will require a significant portion of consumers under the age of 65 with private health insurance in the United States to use offerings such as ours.
  • We seek to differentiate ourselves through our service-driven culture, product breadth, ecosystem connectivity, and proprietary technology, which enables our members to better save, spend, and invest their healthcare dollars.
  • Our business model provides strong visibility into our future operating performance, with the vast majority of our accounts opened before the start of our fiscal year.
  • We believe we are well-positioned to benefit from the transformation of the healthcare benefits market.
  • We believe that our offerings complement and reinforce one another and that member retention increases as they use their accounts with greater frequency and confidence.
  • We are currently investing in a modernization of our proprietary technology platforms, including through the increasing use of artificial intelligence ('AI') tools and technologies, to support new opportunities and enhance security, privacy and platform infrastructure, while maintaining existing applications, features, and services.
  • We believe that our 'Purple' culture is a significant factor in our ability to attract and retain customers and to address opportunities in the rapidly changing healthcare sector.
  • Management reviews and updates our systems of internal controls and procedures, as appropriate.
  • We believe our existing cash, cash equivalents, and Revolving Credit Facility will be sufficient to meet our operating and capital expenditure requirements for at least the next 12 months.

Industry Context

StockSavvy.ai notes that HealthEquity's strong growth in HSA assets and accounts aligns with the broader industry trend of increasing consumer responsibility for healthcare costs and the rising adoption of high-deductible health plans (HDHPs). The passage of the 'One Big Beautiful Bill Act' further supports this trend by expanding HSA eligibility, providing a tailwind for companies in this sector. The company's focus on technology and AI integration is critical in a competitive landscape where players like Fidelity Investments and Optum are also investing heavily, indicating a strategic move to maintain differentiation and efficiency.

Comparison to Industry Standards

  • HealthEquity is the largest HSA provider by number of accounts and the second largest by HSA Assets as of June 2025, according to the 2025 Midyear Devenir HSA Research Report, demonstrating a leading position against competitors like Fidelity Investments, UnitedHealth Group's Optum, and Webster Bank.
  • The company's market share of HSA Assets increased from 4% in December 2010 to 20% in June 2025, indicating significant outperformance relative to the overall HSA market growth.
  • The average family premium for health insurance has risen by 26% since 2020 and 53% since 2015, according to the 2025 KFF Employer Health Benefits Survey, which HealthEquity leverages by providing HSA-qualified health plans.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President and Chief Executive OfficerJon KesslerScott CutlerNovember 11, 2024Retirement of former chief executive officer.
DirectorNAAdrian DillonDecember 20, 2025Entered into a Rule 10b5-1 trading arrangement for stock sales.
DirectorNAGayle WellbornJanuary 14, 2026Entered into a Rule 10b5-1 trading arrangement for stock sales.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdoptionThe board of directors adopted a Code of Business Conduct and Ethics applicable to all team members, officers, and directors.NAEnhances ethical standards and compliance across the organization.
Committee OversightThe Talent, Compensation and Culture Committee provides oversight on executive compensation, company culture, and talent management, development, and retention efforts.NAStrengthens governance over human capital and compensation strategies.
Committee OversightThe Cybersecurity and Technology Committee provides oversight of the Company's cybersecurity threat landscape, risks, and data security programs.NAEnhances board-level scrutiny and management of critical cybersecurity risks.
Committee OversightThe Audit and Risk Committee provides an additional layer of cybersecurity oversight as part of the Company's enterprise risk management program.NAReinforces comprehensive risk management, including cybersecurity, at the board level.
Policy AdoptionAdopted a Clawback Policy in accordance with Nasdaq Listing Rule 5608(a), providing for the recoupment of erroneously awarded incentive compensation on a no-fault basis.October 2, 2023Aligns executive incentives with financial integrity and stockholder interests, deterring wrongdoing.
Policy AmendmentAmended and Restated Non-Employee Director Compensation Policy to establish policies regarding cash compensation and equity grants to Non-Employee Directors.NAProvides clear guidelines for director compensation, aligning interests with stockholders and aiding in attraction/retention of qualified directors.

Legal Proceedings

  • Subject to multiple legal actions, including a consolidated putative class action lawsuit in federal court in the District of Utah, related to a 2024 cybersecurity incident where a business partner's user account containing personally identifiable information was breached.
  • Plaintiffs in these legal actions allege that the Company failed to implement reasonable data security practices and are seeking unspecified monetary damages, equitable relief, costs, and attorneys' fees.
  • On May 5, 2025, the court dismissed without prejudice the Company's motion to compel arbitration and the motion to dismiss, noting the Company could refile both motions after the conclusion of discovery.
  • Subject to several regulatory inquiries related to the 2024 cybersecurity incident.
  • Involved in various other litigation, governmental proceedings, and claims that arise in the normal course of business, for which no loss accrual was recorded as contingent liabilities are not deemed probable or estimable.

Stakeholder Impact

  • Shareholders: Positive impact from increased net income, Adjusted EBITDA, and stock repurchase programs. Potential negative impact from ongoing legal proceedings and cybersecurity risks.
  • Employees (Team Members): Benefit from company investments in human capital, including technology-enabled training, career development, and advancement opportunities. High team member engagement (78% favorable in October 2025) and a focus on pay equity through a 'Total Rewards' package. Total team member turnover was 25% and voluntary turnover was 10% for the fiscal year ended January 31, 2026.
  • Customers (Members, Clients, Network Partners): Benefit from technology-enabled services, product breadth, ecosystem connectivity, and a 'Purple' service culture. Potential negative impact from cybersecurity breaches, fraudulent activity, or service disruptions.
  • Creditors: The Company has substantial debt ($961.9 million principal outstanding) which could limit financial flexibility, but was in compliance with all covenants under its Credit Agreement as of January 31, 2026.

Next Steps

  • Continue investing in technology modernization, including AI tools, to support new opportunities and enhance security, privacy, and platform infrastructure.
  • Continue to focus on brand awareness and Client and member engagement programs, including campaigns to reach individuals newly eligible for HSAs under recent legislative expansion.
  • Complete the remaining merger integration activities.
  • Continue the current level of capital expenditures during the fiscal year ending January 31, 2027, to improve the architecture and functionality of proprietary systems.
  • Vigorously defend against the consolidated putative class action lawsuits and respond to regulatory inquiries related to the 2024 cybersecurity incident.
  • Evaluate the effect of new accounting pronouncements (ASU 2024-03 and ASU 2025-06) on consolidated financial statements and related disclosures.

Key Dates

DateDescription
September 18, 2002HealthEquity, Inc. was incorporated as a Delaware corporation.
February 2006HealthEquity received designation by the U.S. Department of Treasury to act as a passive non-bank custodian.
July 24, 2017HealthEquity received designation by the U.S. Department of Treasury to act as both a passive and non-passive non-bank custodian.
October 8, 2021The Company completed its offering of $600 million aggregate principal amount of its 4.50% Senior Notes due 2029.
October 2, 2023Effective date of the Company's Clawback Policy.
January 17, 2024Date of Michael Fiore's Employment Agreement with the Company.
2024Cybersecurity incident occurred in which a business partner's user account containing personally identifiable information was breached.
August 22, 2024Court issued an order granting a motion to consolidate class action lawsuits related to the 2024 cybersecurity incident.
August 23, 2024The Company entered into a Credit Agreement for a five-year senior secured revolving credit facility of up to $1.0 billion.
August 31, 2024A $300 million common stock repurchase program was approved.
November 11, 2024Date of Scott R. Cutler's Employment Agreement with the Company.
November 11, 2024Date of Jon Kessler's Letter Agreement with the Company.
December 13, 2024The Company filed a motion to dismiss and a motion to compel arbitration for the class action lawsuit related to the 2024 cybersecurity incident.
May 5, 2025Court dismissed without prejudice the Company's motion to compel arbitration and the motion to dismiss, noting the Company could refile after the conclusion of discovery.
June 2025HealthEquity was the largest HSA provider by number of accounts and the second largest by HSA Assets, according to the 2025 Midyear Devenir HSA Research Report.
June 2025The Company's board of directors authorized a new common stock repurchase program (the '2025 Stock Repurchase Program') for up to an additional $300 million.
July 2025The 'One Big Beautiful Bill Act' was signed into law, expanding HSA availability and eligibility.
July 31, 2025The aggregate market value of voting and non-voting common equity held by non-affiliates was approximately $7.0 billion.
October 2025Team member engagement score was 78% favorable, based on an 86% participation rate.
November 1, 2025 November 30, 2025The Company repurchased 217,000 shares of common stock at an average price of $98.99 per share.
December 1, 2025 December 31, 2025The Company repurchased 289,000 shares of common stock at an average price of $94.85 per share.
December 20, 2025Adrian Dillon, a director, entered into a Rule 10b5-1 trading arrangement.
January 1, 2026 January 31, 2026The Company repurchased 371,000 shares of common stock at an average price of $86.94 per share.
January 14, 2026Gayle Wellborn, a director, entered into a Rule 10b5-1 trading arrangement.
January 31, 2026Fiscal year ended.
March 3, 202684,478,406 shares of the Company's common stock were outstanding.
March 17, 2026Filing date of the Annual Report on Form 10-K.
March 21, 2026 February 1, 2027Sale period for Adrian Dillon's Rule 10b5-1 trading arrangement.
April 15, 2026 December 31, 2026Sale period for Gayle Wellborn's Rule 10b5-1 trading arrangement.
January 31, 2027Expected end of fiscal year for which service costs are expected to remain steady and capital expenditures continue at current levels.
January 31, 2028Market condition measurement date for Performance Restricted Stock Units (PRSUs) awarded in fiscal year 2026.
August 23, 2029Maturity date of the Revolving Credit Facility.
October 1, 2029Maturity date of the 4.50% Senior Notes.
December 15, 2026Effective date for ASU 2024-03, 'Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures'.
December 15, 2027Effective date for ASU 2025-06, 'Intangibles-Goodwill and Other-Internal-Use Software'.
January 31, 2036State net operating loss carryforwards begin to expire.

Recommendation

strong buy

The company demonstrated exceptional financial performance with a 123% increase in net income and 20% Adjusted EBITDA growth, driven by robust HSA asset and account expansion. Strategic investments in technology, including AI, and successful acquisitions position HealthEquity for continued market leadership in a growing sector. While legal and cybersecurity risks exist, the strong operational efficiencies and legislative tailwinds suggest significant upside potential for investors.

Keywords

HSA, Health Savings Accounts, CDB, Consumer-Directed Benefits, Financial Services, Healthcare Technology, Fintech, Wealth Management, Investment Advisory, SEC Filing, 10-K, HealthEquity, HQY, Corporate Governance, Risk Management, Financial Reporting, AI, Cybersecurity, BenefitWallet, Acquisitions, Stock Repurchase

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.